Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
Quick Stats
Jan 30, 202658.0
AI Score
HOLD0.98
Volume Ratio
Feb 26, 2026
Next Earnings
17
+ve Days (30d)
13
-ve Days (30d)
CGEM Stock Summary
Last updated Jan 30, 2026
CGEM is currently trading at $11.96, positioned above its 200-day moving average of $8.46, indicating a long-term uptrend. The stock has a 52-week range of $5.68 to $13.33.
Technical Analysis: The 50-day moving average stands at $10.86, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 58.598, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.051, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CGEM at 58.0/100 with a HOLD recommendation.
CGEM (Cullinan Therapeutics, Inc. Common Stock) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 58.598 |
| CMF (20) | 0.051 |
| ROC (10) | 12.195 |
| ADX (14) | 21.671 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.477 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -34.915 |
| MFI (14) | 64.268 |
CGEM Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CGEM Price vs Max Options Open Interest
CGEM Max Change In Options Open Interest
CGEM Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CGEM Daily Out of Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CGEM Daily In the Money Options - Sort by Max open Interest (near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CGEM Most Active Options by Volume(near term)
31st January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Cullinan Therapeutics, Inc. Common Stock is above both 50 Day and 200 Day SMA which is considered Bullish.
CGEM Moving Averages Analysis
Cullinan Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Cullinan Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
CGEM (Cullinan Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 11.83 |
| 20 | 11.22 |
| 30 | 10.84 |
| 50 | 10.86 |
| 100 | 9.01 |
| 200 | 8.46 |
CGEM Fundamental Analysis
| P/E (Forward) | 6.3012 |
| P/E (Trailing) | -- |
| Market Cap ($) | 700.1 million |
| Earnings/Share ($) | -3.32 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.6068 |
| EPS Estimate Next Year ($) | -3.318 |
| WallStreet Target Price ($) | 29.4333 |
| Most Recent Quarter |